GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Synta Pharmaceuticals Corp. (SNTA) [hlAlert]

Synta Pharmaceuticals Corp. is a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to extend and enhance the lives of patients with severe medical conditions, including cancer and chronic
inflammatory diseases. The Company has three clinical-stage drug candidates and several drug candidates in the preclinical and discovery stages. In December 2008, the Company entered into a partnership with Hoffmann-La Roche for its CRACM inhibitor program. The Company?s drug candidates include Elesclomol, STA-9090, STA-9584, Apilimod (STA-5326), Oral CRACM channel inhibitor and CRAC channel inhibitor. The Company has two clinical-stage programs and one preclinical-stage program in oncology.
.
( Total: 16 Current Stock Recommendations )
Synta Pharmaceuticals Corp.   (16)
Sell Hold 38% Buy 50%
Related companies
Eli Lilly And ...   (29)
Sell Hold 34% Buy 52%
Novartis Ag   (19)
Sell Hold 32% Buy 58%
Pfizer, Inc.   (27)
Sell Hold 22% Buy 70%
TONGITANG CHINESE ...   (2)
Hold 100%
Achillion ...   (15)
Sell Hold 27% Buy 67%
Alcon Inc   (11)
Hold 64% Buy 36%
Bristol-myers ...   (23)
Sell Hold 30% Buy 65%
Johnson & Johnson   (33)
Sell Hold 27% Buy 70%
Prestige Brand ...   (6)
Sell 17% Hold 50% Buy 33%
Merck & Company, ...   (24)
Hold 25% Buy 75%
Show  

Date (ET)MemberRatingYTD
Gains
 
3/12/2014  
Sell
  
3/13/2014  
Buy
  
11/9/2010  
Buy
  
2/28/2011  
Buy
  
10/21/2015  
Hold
  
1/5/2012  
Buy
  
6/2/2008  
Buy
  
2/27/2009  
Sell
  
2/19/2010  
Hold
  
2/27/2009  
Hold
  
8/30/2012  
Hold
  
10/21/2015  
Hold
  
8/26/2010  
Buy
  
7/16/2013  
Buy
  
3/12/2008  
Buy
  
12/1/2008  
Hold
  

* As of 8/27/2015 12:00 AM
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy